Samuel R Saks's Net Worth

$43.4 Million

Estimate Recalculated May 24, 2024 04:14PM EST

Who is Samuel R Saks?

Samuel R Saks has an estimated net worth of $43.4 Million. This is based on reported shares across multiple companies, which include Auspex Pharmaceuticals, Inc., Cougar Biotechnology, Inc., Trubion Pharmaceuticals, Inc, JAZZ PHARMACEUTICALS INC, Protagonist Therapeutics, Inc, Tonix Pharmaceuticals Holding Corp., PDL BIOPHARMA, INC., and DEPOMED INC.

SEC CIK

Samuel R Saks's CIK is 0001365615

Past Insider Trading and Trends

2007 was Samuel R Saks's most active year for acquiring shares with 22 total transactions. Samuel R Saks's most active month to acquire stocks was the month of October. 2015 was Samuel R Saks's most active year for disposing of shares, totalling 7 transactions. Samuel R Saks's most active month to dispose stocks was the month of April. 2019 saw Samuel R Saks paying a total of $378,150.00 for 188,550 shares, this is the most they've acquired in one year. In 2009 Samuel R Saks cashed out on 45,000 shares for a total of $881,550.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Auspex Pharmaceuticals, Inc. No price found

Chief Development Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-67.34K
—
—
0
May 5
Form 4
—
0
—
—
0
Feb 2
Form 4
+3.53%
2.17K
$12.00
$26,100.00
63.84K
Feb 10
Form 3
—
0
—
—
0
No matching records found

Cougar Biotechnology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 3
Form 4
—
0
—
—
0
Sep 12
Form 3
—
0
—
—
0
No matching records found

Trubion Pharmaceuticals, Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 28
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 25
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

JAZZ PHARMACEUTICALS INC (JAZZ) Snapshot price: $123.23

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 21
Form 4
+0.32%
1.15K
$1.28
$1,466.88
358.87K
Nov 28
Form 4
+0.38%
1.34K
$6.50
$8,697.00
357.72K
May 30
Form 4
+2.53%
8.79K
—
—
356.38K
May 16
Form 4
+0.17%
590
$13.18
$7,776.20
347.59K
Nov 30
Form 4
+1.43%
4.9K
$13.40
$65,642.00
347K
Nov 14
Form 4
+7.46%
23.74K
$13.42
$318,454.73
342.1K
Nov 12 - Nov 13
Form 4
+33.46%
79.82K
—
—
318.36K
Jun 6
Form 3
—
0
—
—
0
No matching records found

Protagonist Therapeutics, Inc (PTGX) Snapshot price: $25.49

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+600.00%
12K
—
—
14K
Feb 26
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
May 15
Form 4
∞
2.5K
—
—
2.5K
Feb 28
Form 4
—
0
—
—
0
May 31
Form 3
—
0
—
—
0
No matching records found